Zevenbergen Capital Investments LLC Lowers Stake in Axon Enterprise, Inc. (NASDAQ:AXON)

Zevenbergen Capital Investments LLC decreased its position in shares of Axon Enterprise, Inc. (NASDAQ:AXON) by 12.7% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 423,239 shares of the biotechnology company’s stock after selling 61,819 shares during the quarter. Axon Enterprise makes up 5.1% of Zevenbergen Capital Investments LLC’s investment portfolio, making the stock its 5th largest position. Zevenbergen Capital Investments LLC owned approximately 0.56% of Axon Enterprise worth $251,539,000 at the end of the most recent quarter.

Other large investors also recently added to or reduced their stakes in the company. Asset Dedication LLC boosted its holdings in shares of Axon Enterprise by 11.3% in the fourth quarter. Asset Dedication LLC now owns 178 shares of the biotechnology company’s stock worth $106,000 after acquiring an additional 18 shares during the period. Bleakley Financial Group LLC boosted its stake in Axon Enterprise by 1.3% in the 4th quarter. Bleakley Financial Group LLC now owns 1,527 shares of the biotechnology company’s stock worth $908,000 after purchasing an additional 20 shares during the period. Venturi Wealth Management LLC grew its holdings in Axon Enterprise by 2.7% during the 4th quarter. Venturi Wealth Management LLC now owns 802 shares of the biotechnology company’s stock valued at $477,000 after buying an additional 21 shares in the last quarter. Insigneo Advisory Services LLC increased its position in shares of Axon Enterprise by 1.4% during the third quarter. Insigneo Advisory Services LLC now owns 1,568 shares of the biotechnology company’s stock valued at $627,000 after buying an additional 22 shares during the period. Finally, Menard Financial Group LLC lifted its holdings in shares of Axon Enterprise by 0.8% in the third quarter. Menard Financial Group LLC now owns 3,014 shares of the biotechnology company’s stock worth $1,204,000 after buying an additional 24 shares in the last quarter. Hedge funds and other institutional investors own 79.08% of the company’s stock.

Axon Enterprise Price Performance

Shares of Axon Enterprise stock opened at $560.00 on Monday. The firm has a market cap of $42.91 billion, a PE ratio of 144.70, a price-to-earnings-growth ratio of 5.17 and a beta of 1.12. The company’s fifty day simple moving average is $591.90 and its two-hundred day simple moving average is $543.57. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. Axon Enterprise, Inc. has a 12-month low of $273.52 and a 12-month high of $715.99.

Analysts Set New Price Targets

Several analysts have issued reports on the stock. The Goldman Sachs Group increased their target price on shares of Axon Enterprise from $500.00 to $700.00 and gave the stock a “buy” rating in a research note on Monday, January 27th. Northcoast Research lowered Axon Enterprise from a “buy” rating to a “neutral” rating in a research note on Wednesday, February 19th. Craig Hallum lowered Axon Enterprise from a “buy” rating to a “cautious” rating in a research note on Monday, March 10th. Morgan Stanley upgraded Axon Enterprise from an “equal weight” rating to an “overweight” rating and lifted their price target for the company from $500.00 to $700.00 in a research report on Tuesday, December 3rd. Finally, Robert W. Baird upped their price objective on shares of Axon Enterprise from $600.00 to $800.00 and gave the stock an “outperform” rating in a research report on Friday, December 6th. One equities research analyst has rated the stock with a sell rating, two have issued a hold rating and eleven have given a buy rating to the stock. Based on data from MarketBeat, Axon Enterprise currently has a consensus rating of “Moderate Buy” and a consensus target price of $604.67.

Insider Activity at Axon Enterprise

In related news, Director Jeri Williams sold 307 shares of the stock in a transaction dated Monday, March 17th. The shares were sold at an average price of $552.72, for a total value of $169,685.04. Following the completion of the transaction, the director now directly owns 1,627 shares of the company’s stock, valued at $899,275.44. This represents a 15.87 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Director Caitlin Elizabeth Kalinowski sold 450 shares of the stock in a transaction that occurred on Thursday, January 2nd. The stock was sold at an average price of $604.07, for a total value of $271,831.50. Following the completion of the transaction, the director now directly owns 6,929 shares of the company’s stock, valued at $4,185,601.03. This represents a 6.10 % decrease in their position. The disclosure for this sale can be found here. 6.10% of the stock is owned by company insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.